Background Although numerous mouse models of breast carcinomas have been developed, we do not know the extent to which any faithfully represent clinically significant human …
KA Hoadley, VJ Weigman, C Fan, LR Sawyer, X He… - BMC genomics, 2007 - Springer
Background The epidermal growth factor receptor (EGFR/HER1) and its downstream signaling events are important for regulating cell growth and behavior in many epithelial …
J Usary, DB Darr, AD Pfefferle… - Current protocols in …, 2016 - Wiley Online Library
Advances in the screening of new therapeutic options have significantly reduced the breast cancer death rate over the last decade. Despite these advances, breast cancer remains the …
Insulin-like growth factors (IGFs) play a crucial role in regulating cell proliferation and differentiation. The aim of this study was to examine the potential relationship between …
PJ Roberts, JE Usary, DB Darr, PM Dillon… - Clinical cancer …, 2012 - AACR
Purpose: Anticancer drug development is inefficient, but genetically engineered murine models (GEMM) and orthotopic, syngeneic transplants (OST) of cancer may offer …
O Aprelikova, K Chen, LH El Touny… - Clinical …, 2016 - Springer
Background Oncogene overexpression in primary cells often triggers the induction of a cellular safeguard response promoting senescence or apoptosis. Secondary cooperating …
MA Shibata, C Kavanaugh, E Shibata, H Abe… - …, 2003 - academic.oup.com
The effects of lovastatin, a potent inhibitor of HMG CoA reductase, on experimental mammary and prostate oncogenesis, were studied in vitro and in vivo. Lovastatin inhibited …
JE Green, MA Shibata, E Shibata, RC Moon, MR Anver… - Cancer research, 2001 - AACR
Female transgenic mice that express SV40 T/t antigens under the regulatory control of the rat C3 (1) gene spontaneously develop multifocal mammary lesions that predictably evolve …
Active Ras proteins contribute to breast carcinogenesis and progression. Here, we provide evidence that active H-Ras regulates the expression and activity of the E2F family of …